These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 36841736)

  • 41. The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments.
    Son YM; Kim J
    J Microbiol Biotechnol; 2022 Sep; 32(9):1086-1097. PubMed ID: 36116940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset.
    Wang C; Ma A; Li Y; McNutt ME; Zhang S; Zhu J; Hoyd R; Wheeler CE; Robinson LA; Chan CHF; Zakharia Y; Dodd RD; Ulrich CM; Hardikar S; Churchman ML; Tarhini AA; Singer EA; Ikeguchi AP; McCarter MD; Denko N; Tinoco G; Husain M; Jin N; Osman AEG; Eljilany I; Tan AC; Coleman SS; Denko L; Riedlinger G; Schneider BP; Spakowicz D; Ma Q;
    Cancer Res Commun; 2024 Feb; 4(2):293-302. PubMed ID: 38259095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
    Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
    Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An introduction to microbiome analysis for human biology applications.
    Amato KR
    Am J Hum Biol; 2017 Jan; 29(1):. PubMed ID: 27762069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments.
    Brandi G; Frega G
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The human microbiome and cancer: a diagnostic and therapeutic perspective.
    Kandalai S; Li H; Zhang N; Peng H; Zheng Q
    Cancer Biol Ther; 2023 Dec; 24(1):2240084. PubMed ID: 37498047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The microbiome and precision oncology: an emerging paradigm in anticancer therapy.
    Bhat SA; Kaur R; Chauhan A; Pal A
    Crit Rev Microbiol; 2022 Nov; 48(6):770-783. PubMed ID: 35164642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression.
    Souza VGP; Forder A; Pewarchuk ME; Telkar N; de Araujo RP; Stewart GL; Vieira J; Reis PP; Lam WL
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Microbiome and Genitourinary Cancer: A Collaborative Review.
    Markowski MC; Boorjian SA; Burton JP; Hahn NM; Ingersoll MA; Maleki Vareki S; Pal SK; Sfanos KS
    Eur Urol; 2019 Apr; 75(4):637-646. PubMed ID: 30655087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intratumoral microbiota: new frontiers in tumor immunity.
    Zhang Z; Liao Y; Tang D
    Carcinogenesis; 2022 Sep; 43(8):719-727. PubMed ID: 35868230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deciphering the human microbiome using next-generation sequencing data and bioinformatics approaches.
    Kim Y; Koh I; Rho M
    Methods; 2015 Jun; 79-80():52-9. PubMed ID: 25448477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy.
    Chen J; Li T; Liang J; Huang Q; Huang JD; Ke Y; Sun H
    Biomed Pharmacother; 2022 Jan; 145():112443. PubMed ID: 34847476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrating the human microbiome in the forensic toolkit: Current bottlenecks and future solutions.
    Díez López C; Vidaki A; Kayser M
    Forensic Sci Int Genet; 2022 Jan; 56():102627. PubMed ID: 34742094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamic interaction network inference from longitudinal microbiome data.
    Lugo-Martinez J; Ruiz-Perez D; Narasimhan G; Bar-Joseph Z
    Microbiome; 2019 Apr; 7(1):54. PubMed ID: 30940197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut microbiome and cancer immunotherapy.
    Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
    J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
    Pandey P; Khan F
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
    Chen Y; Liu B; Wei Y; Kuang DM
    Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of intestinal microbiota in tumor occurrence, development and immunotherapy: a review].
    Deng H; Fan X
    Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2105-2119. PubMed ID: 35786465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.